Is the Aviva share price a FTSE 100 bargain or a value trap?

Royston Wild examines whether FTSE 100 (INDEXFTSE: UKX) giant Aviva plc (LON: AV) could be the big-cap beauty you’ve been looking for.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

There are plenty of bona fide bargains strewn across the FTSE 100 index that can be picked up today. And going by the numbers alone, Aviva (LSE: AV) would be considered by some as falling into that category.

Thanks to City predictions of a 63% profits rise in 2018, the insurance giant carries a forward P/E of 9.4 times, inside the accepted bargain territory of 10 times or below. And what’s more, this stunning earnings projection also results in a corresponding sub-1 PEG reading of 0.1.

But is Aviva a genuine value star or a simple value trap waiting to trip you up?

Profits pounding higher

The Square Mile’s many analysts do not expect this year’s predicted rise to be the end of the matter and they are anticipating another 7% profits rise in 2019.

It’s easy to see why the experts are predicting sustained profit progression at Aviva. Last year the company’s market share grab in its core UK market helped revenues to keep driving through the roof. And the long-term structural opportunities created by solid economic growth, a rapidly-ageing population, and changing regulatory requirements provide plenty of scope for profits to keep rising.

These factors are not confined to its home marketplace either. Indeed, Aviva reported that profits leapt by double-digit percentages across three-quarters of its eight major territories in 2017.

What’s more, I am also pretty excited over the war chest it has for earnings-boosting M&A action in the near term and beyond. Indeed, it has recently earmarked £500m (which includes the £100m dedicated to the takeover of Ireland’s Friends First) for the pursuit of bolt-on acquisitions in its white-hot geographies.

Stunning yields

Arguably Aviva’s strongest pull is the promise of monster dividend yields, however.

The Footsie firm has almost doubled dividends over the past five years and brokers are predicting extra growth in the medium term at least. Last year’s 27.4p per share reward is anticipated to leap again to 29p in 2018, and then to 32.4p next year.

As a consequence, yields clock in at an eye-popping 5.4% and 6% for 2018 and 2019 respectively.

Indeed, with Aviva throwing up so much cash, it is also rewarding its shareholders by embarking on a massive share buyback scheme. The company plans to buy a maximum of £600m worth of shares and launched the operation at the turn of the month.

Now Aviva isn’t without its share of risk, of course. As my fellow Foolish writer Rupert Hargreaves pointed out recently, the firm almost followed the dinosaurs into extinction when the last financial crisis hit. And there are many signals flashing in the global economy that, despite the huge restructuring that has taken place since then, would unquestionably see the insurer come under huge strain yet again.

Having said that, I reckon these factors are more than baked into the FTSE 100 giant’s dirt-cheap earnings multiple. In my opinion it is a terrific blue-chip to buy today.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »